Open-channel blockade is less effective on GluN3B than GluN3A subunit-containing NMDA receptors
David W. McClymont, John Harris, Ian R. Mellor
Index: Eur. J. Pharmacol. 686(1-3) , 22-31, (2012)
Full Text: HTML
Abstract
The GluN3 subunits of the N-methyl-d-aspartate (NMDA) receptor are known to reduce its Ca2+ permeability and Mg2+ sensitivity, however, little is known about their effects on other channel blockers. cRNAs for rat NMDA receptor subunits were injected into Xenopus oocytes and responses to NMDA and glycine were recorded using two electrode voltage clamp. Channel block of receptors containing GluN1-1a/2A, GluN1-1a/2A/3A or GluN1-1a/2A/3B subunits was characterised using Mg2+, memantine, MK-801, philanthotoxin-343 and methoctramine. IC50 values for Mg2+ and memantine increased when receptors contained GluN3A subunits and were further increased when they contained GluN3B, e.g. IC50s at −75mV for block of GluN1-1a/2A, GluN1-1a/2A/3A and GluN1-1a/2A/3B receptors respectively were 4.2, 22.4 and 40.1μM for Mg2+, and 2.5, 7.5 and 17.5μM for memantine. Blocking activity was found to be fully or partially restored when G or R (at the N and N+1 sites respectively) were mutated to N in GluN3A. Thus, the changes cannot be attributed to the loss of the N or N+1 sites alone, but rather involve both sites or residues elsewhere. Block by MK-801 and philanthotoxin-343 was also reduced by GluN3A, most strongly at −100mV but not at −50mV, and by GluN3B at all Vh. Methoctramine was the least sensitive to introduction of GluN3 subunits suggesting a minimal interaction with the N and N+1 sites. We conclude that GluN3B-containing receptors provide increased resistance to channel block compared to GluN3A-containing receptors and this must be due to differences outside the deep pore region (N site and deeper).
Related Compounds
Related Articles:
1996-01-19
[J. Med. Chem. 39(2) , 515-21, (1996)]
A sequential high-yielding large-scale solution-method for synthesis of philanthotoxin analogues.
2003-01-01
[Eur. J. Med. Chem. 38(1) , 117-22, (2003)]
1997-09-01
[Br. J. Pharmacol. 122(2) , 379-85, (1997)]
2000-01-01
[Receptors Channels 7(3) , 227-36, (2000)]
1995-05-01
[J. Neurochem. 64(5) , 2043-8, (1995)]